Avalyn Share Price

Avalyn Share Price

NASDAQ: AVLN | Healthcare
$28.45
-$0.20 (-0.7%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • About
  • Price history
  • FAQs

Avalyn Stock Performance

Open
$28.73
Prev. Close
$28.65
Circuit Range
N/A
Day Range
$27.88 - $29.14
Year Range
$22.89 - $39.95
Volume
13,772
Average Traded
$28.57

Avalyn Share Price Today

As of 22 November 2026, Avalyn Pharma Inc.'s share price is $28.45. The stock opened at $28.73, compared to its previous close of $28.65. During today's trading session, Avalyn Pharma Inc.'s share price traded between $27.88 and $29.14, with an average price of $28.51. Over the past 52 weeks, the stock has recorded a high of $39.95 and a low of $22.89. In terms of performance, Avalyn Pharma Inc.'s share price has declined by 0.63% over the last six months and is down 2.20% on a year-on-year basis.

Avalyn Share Price Chart

Line chart of the Avalyn price trend over the selected period. The price fell overall, ranging from 27.89 to 29.25, ending at 28.45.
$27.88$29.14
L
Show Current Price
H

Avalyn Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.92
Revenue (TTM)
N/A
Return On Equity (TTM)
-23.08%
Profit Margin
N/A
Debt to Equity
0.04
Quarterly Earnings Growth YoY
N/A

Avalyn Quarterly Profit & Loss

All figures in USD

ParticularsJun 2026Sep 2026
Revenue$0.00$0.00
Net Profit-$28.94-$29.66
Net Profit MarginN/AN/A
Income ChangeN/A-2.49%

About Avalyn

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Avalyn Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$25.68
$28.43
+10.95%
Oct 2026
$27.75
$25.63
-10.29%
Sep 2026
$35.39
$28.57
-21.76%
Aug 2026
$28.02
$36.51
+27.06%
Jul 2026
$32.53
$28.73
-12.61%
Jun 2026
$28.00
$32.88
+14.84%
May 2026
$27.73
$28.63
-1.58%
Apr 2026
$26.00
$29.09
N/A

Avalyn Share Price FAQs